Analysts speculate KPC Pharmaceuticals' high P/E ratio is du...
Analysts speculate KPC Pharmaceuticals' high P/E ratio is due to its superior earnings outlook. Shareholders retain their comfort with the P/E, confident of future earnings stability. Shares expected to remain stable given these conditions.
KPC Pharmaceuticals,Inc (SHSE:600422) Not Lagging Market On Growth Or Pricing
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment